Published in Dtsch Med Wochenschr on April 16, 1999
[Prospective epidemiological study of epigastric complaints (PRESTO)]. Dtsch Med Wochenschr (2000) 0.75
[Prospective epidemiological study of epigastric complaints (PRESTO)]. Dtsch Med Wochenschr (2000) 0.75
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med (2001) 7.71
Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med (2000) 4.98
Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet (2000) 4.83
Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci U S A (1999) 4.55
Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology (1998) 3.95
Anti-GOR and hepatitis C virus in autoimmune liver diseases. Lancet (1992) 3.33
Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med (1989) 3.03
[Endoscopic sphincterotomy of the papilla of vater and extraction of stones from the choledochal duct (author's transl)]. Dtsch Med Wochenschr (1974) 3.03
Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest (1998) 2.90
Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology (1993) 2.83
Complications of diagnostic gastrointestinal endoscopy. Endoscopy (1990) 2.69
Relation of smoking and alcohol and coffee consumption to active Helicobacter pylori infection: cross sectional study. BMJ (1997) 2.65
p300 acts as a transcriptional coactivator for mammalian Notch-1. Mol Cell Biol (2001) 2.64
Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene (1997) 2.58
Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med (2001) 2.56
Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques. Gut (2003) 2.49
Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study. Lancet (2001) 2.39
Regulation of gastric epithelial cell growth by Helicobacter pylori: offdence for a major role of apoptosis. Gastroenterology (1997) 2.39
Pancreatography in chronic pancreatitis: international definitions. Gut (1984) 2.37
Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res (2001) 2.29
Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci (1989) 2.23
Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir. Aliment Pharmacol Ther (2013) 2.21
NF-kappaB/Rel activation in cerulein pancreatitis. Gastroenterology (1999) 2.21
Evaluating pain and the quality of life in chronic pancreatitis. Int J Pancreatol (1997) 2.16
Current status of screening colonoscopy in Europe and in the United States. Endoscopy (2007) 2.14
[Phenprocoumon-induced necrotizing hepatitis]. Dtsch Med Wochenschr (2001) 2.08
Endoscopic closure of esophageal intrathoracic leaks: stent versus endoscopic vacuum-assisted closure, a retrospective analysis. Endoscopy (2013) 2.08
Endoscopic papillary balloon dilation vs. sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study. Endoscopy (2001) 2.07
A major fraction of human intraepithelial lymphocytes simultaneously expresses the gamma/delta T cell receptor, the CD8 accessory molecule and preferentially uses the V delta 1 gene segment. Eur J Immunol (1991) 2.06
A sonographically guided technique for central venous access. AJR Am J Roentgenol (1997) 2.05
A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev (2001) 2.05
Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D. Lancet (1994) 2.05
[S3-Guidelines Conference "Colorectal Carcinoma" 2004]. Z Gastroenterol (2004) 2.03
Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy (1999) 2.02
Parental smoking and infection with Helicobacter pylori among preschool children in southern Germany. Epidemiology (1998) 1.98
Enhanced production of monocyte chemotactic protein 3 in inflammatory bowel disease mucosa. Gut (1999) 1.97
Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C. Gut (2001) 1.97
NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa. Mol Cell Biol (1998) 1.96
Helicobacter pylori among preschool children and their parents: evidence of parent-child transmission. J Infect Dis (1999) 1.96
Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study. Lancet (2000) 1.94
[HYGEA (Hygiene in gastroenterology--endoscope reprocessing): Study on quality of reprocessing flexible endoscopes in hospitals and in the practice setting]. Z Gastroenterol (2002) 1.93
Metabolic and weight-loss effects of a long-term dietary intervention in obese patients. Am J Clin Nutr (1999) 1.92
Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells. Cancer Res (2000) 1.90
Mutations of the cystic fibrosis gene, but not cationic trypsinogen gene, are associated with recurrent or chronic idiopathic pancreatitis. Am J Gastroenterol (2000) 1.90
Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol (1998) 1.89
Intra-acinar cell activation of trypsinogen during caerulein-induced pancreatitis in rats. Am J Physiol (1998) 1.89
Expert opinion on the treatment of patients with chronic hepatitis C. J Viral Hepat (2008) 1.85
Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol (1997) 1.83
Association between fulminant hepatic failure and a strain of GBV virus C. Lancet (1996) 1.82
Is stenting necessary after balloon dilation of post-transplantation biliary strictures? Results of a prospective comparative study. Endoscopy (2008) 1.76
Molecular cloning and characterization of the human protein kinase D2. A novel member of the protein kinase D family of serine threonine kinases. J Biol Chem (2000) 1.76
[Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. Z Gastroenterol (2010) 1.76
Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology (2001) 1.75
Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut (2002) 1.74
Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy (2006) 1.70
Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology (1992) 1.68
Regulation of cell growth and cyclin D1 expression by the constitutively active FRAP-p70s6K pathway in human pancreatic cancer cells. Cancer Res (1999) 1.67
Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res (2001) 1.67
Quality in screening colonoscopy: position statement of the European Society of Gastrointestinal Endoscopy (ESGE). Endoscopy (2012) 1.67
Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J Cancer (1995) 1.67
CFTR and its key role in in vivo resting and luminal acid-induced duodenal HCO3- secretion. Acta Physiol (Oxf) (2008) 1.65
Expression of the highly conserved RNA binding protein KOC in embryogenesis. Mech Dev (1999) 1.64
Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells. EMBO J (2003) 1.64
The relationship between juxtapapillary duodenal diverticula and disorders of the biliopancreatic system: analysis of 350 patients. Gastrointest Endosc (2001) 1.63
CREB controls LAP/C/EBP beta transcription. Mol Cell Biol (1997) 1.62
Percutaneous cholangioscopic or transpapillary insertion of self-expanding biliary metal stents. Gastrointest Endosc (1991) 1.61
Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Mol Pharmacol (1997) 1.61
Long-term results (7 to 10 years) of endoscopic papillotomy for choledocholithiasis. Multivariate analysis of prognostic factors for the recurrence of biliary symptoms. Gastrointest Endosc (1998) 1.60
Analysis of factors contributing to higher erythropoietin levels in patients with chronic liver disease. Scand J Gastroenterol (2004) 1.60
Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. Gastroenterology (1998) 1.60
Expression and differential regulation of connective tissue growth factor in pancreatic cancer cells. Oncogene (1999) 1.60
A prospective evaluation of magnetic resonance cholangiopancreatography in patients with suspected bile duct obstruction. Gut (1998) 1.59
Cerebral responses evoked by electrical stimulation of rectosigmoid in normal subjects. Dig Dis Sci (1989) 1.58
Improved tumor staging by diagnostic laparoscopy. Z Gastroenterol (1999) 1.58
Helicobacter pylori infection: prevalence and clinical relevance in a large company. J Occup Environ Med (1998) 1.57
Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology (2000) 1.56
Metabolic and weight loss effects of long-term dietary intervention in obese patients: four-year results. Obes Res (2000) 1.56
A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. Cancer Res (2000) 1.55
Fibreendoscopy of the intestines. Gut (1971) 1.55
Guanylin strongly stimulates rat duodenal HCO3- secretion: proposed mechanism and comparison with other secretagogues. Gastroenterology (1996) 1.53
Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology (1996) 1.53
Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma. Biochem Biophys Res Commun (1998) 1.52
Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc (1991) 1.52
[S3-guideline colorectal cancer version 1.0]. Z Gastroenterol (2013) 1.51
Frequency of very low HCV viremia detected by a highly sensitive HCV-RNA assay. J Clin Virol (2007) 1.51
Endoscopic injection therapy of Forrest II and III gastroduodenal ulcers guided by endoscopic Doppler ultrasound. Endoscopy (1993) 1.51
Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients. Br J Cancer (2005) 1.51
A pancreatic cancer-specific expression profile. Oncogene (1996) 1.50
Characteristic distribution pattern of Helicobacter pylori in dental plaque and saliva detected with nested PCR. J Med Microbiol (2000) 1.50
A negative rapid urease test is unreliable for exclusion of Helicobacter pylori infection during acute phase of ulcer bleeding. A prospective case control study. Dig Liver Dis (2003) 1.50
Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies. Scand J Gastroenterol (2001) 1.49
Genetic distinctions between types 1 and 2 autoimmune hepatitis. Am J Gastroenterol (1997) 1.49
Pancreatic endoscopic sphincterotomy in patients with chronic pancreatitis: a single-center experience in 171 consecutive patients. Endoscopy (2002) 1.47
Genetic alterations in chronic pancreatitis: evidence for early occurrence of p53 but not K-ras mutations. Br J Surg (1998) 1.46
Aerobilia and hypomotility of the sphincter of Oddi in a patient with chronic intestinal pseudo-obstruction. Gastroenterology (1992) 1.46
A mass in the eye. Lancet (2002) 1.46